MS

Biogen and Abbott advance MS drug candidate
Bizjournals.com
Tue, 08/9/11 - 01:13 pm
DAC HYP
multiple sclerosis
MS
Abbott Laboratories
Biogen Idec
dalcizumab HYP
Teva study gives Biogen a lift
Yahoo/InvestorsBusinessDaily
Tue, 08/2/11 - 11:33 am
Teva Pharmaceuticals
Biogen Idec
MS
multiple sclerosis
laquinimod
Active Biotech shares slump after Phase III result
Marketwatch
Mon, 08/1/11 - 10:22 am
Active Biotech
laquinimod
Teva Pharmaceuticals
MS
multiple sclerosis
Biogen wins conditional EU approval for MS drug
Bizjournals.com
Mon, 07/25/11 - 10:25 am
Biogen Idec
Europe
MS
multiple sclerosis
Fampyra
Biogen, Bayer MS Drugs Aren’t Cost Effective, Study Says
Bloomberg
Thu, 07/21/11 - 12:19 pm
MS
multiple sclerosis
Biogen Idec
Bayer
Avonex
Betaseron
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
Phase III Data Mixed on Sanofi's Lemtrada
Yahoo/Zacks.com
Wed, 07/13/11 - 06:25 pm
Sanofi
Lemtrada
MS
multiple sclerosis
alemtuzumab
Sanofi-Genzyme MS Drug: Mixed Results
TheStreet.com
Mon, 07/11/11 - 09:50 am
MS
multiple sclerosis
Sanofi
Genzyme
Questcor hits 52-week high
Marketwatch
Mon, 07/4/11 - 09:18 am
Questcor Pharmaceuticals
MS
multiple sclerosis
Acthar
Merck Says Submits Application for MS Treatment Rebif in Europe
Bloomberg
Wed, 06/29/11 - 06:54 am
Merck
Rebif
MS
Europe
multiple sclerosis
Acorda Pushes Sales of MS Drug
Minyanville
Wed, 06/29/11 - 12:07 am
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
With cladribine gone, Gilenya takes center stage
Fierce Pharma
Wed, 06/22/11 - 07:35 pm
Gilenya
cladribine
Movectro
MS
multiple sclerosis
Novartis
Merck KGaA
Merck KGaA Slides After Decision Not to Seek MS Drug Approval
Bloomberg
Wed, 06/22/11 - 08:16 am
MS
multiple sclerosis
Merck KGaA
cladribine
Mylan wins on summary judgment
Bizjournals.com
Mon, 06/20/11 - 09:27 am
Mylan
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Analyst raises Acorda target as Ampyra sales grow
Yahoo/AP
Mon, 06/13/11 - 06:11 pm
AMPYRA
Acorda Therapeutics
MS
Biogen Idec
multiple sclerosis
FDA postpones ruling on generic Copaxone
Globes, Israel
Thu, 06/9/11 - 08:06 am
FDA
generics
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Biogen Seeking Deals to Expand Pipeline of MS Treatments
Bloomberg
Wed, 06/8/11 - 08:53 am
MS
multiple sclerosis
Biogen Idec
Biogen says European Union regulators approved once-a-week injection pen for MS
Yahoo/AP
Tue, 06/7/11 - 09:54 am
Biogen Idec
Europe
MS
multiple sclerosis
Avonex pen
Teva begins new double-dose Copaxone trial
Globes, Israel
Thu, 06/2/11 - 10:45 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Novartis’s Gilenya MS Drug Has 10,000 Users in U.S., Mundel Says
Bloomberg
Wed, 05/25/11 - 11:34 am
Novartis
MS
Gilenya
multiple sclerosis

Pages